It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as ...
The S&P 500 has bounced from its drop last week, a decline that had eroded its U.S. election bump without knocking the index ...
Applications for mortgages in the latest week rose in spite of the 30-year rate inching up for the fourth week in a row to ...
The fund manager AllianceBernstein looked at periods where the top 10 stocks dominated over the last three decades.
A former Nomura employee has been charged with robbery, attempted murder, and arson of an inhabited building following an ...
Nvidia is due to report fiscal third-quarter earnings after Wednesday's closing bell. MarketWatch will be breaking down the ...
I am a divorced woman in my 70s. I have accumulated a nice retirement fund and my house is paid off. I will definitely be ...
A staggering waterfront “smart home” that is located in a billionaire-loved Seattle suburb has been put on the market for $22 ...
The U.S. Embassy in Kyiv said it would stay closed Wednesday after receiving a warning of a potentially significant Russian ...
The Houston company late Tuesday said fourth-quarter new orders totaled $267 million, compared with $171 million a year earlier and $356 million in the third quarter. Its backlog totaled $1.3 billion ...
Sage Therapeutics Inc.’s stock fell 2% early Wednesday after the company said it would cease the development of a treatment for cognitive impairment associated with Huntington’s disease after a failed ...
Metro said the Toronto Stock Exchange has approved the renewal of the retailer's normal course issuer bid program, which could see it repurchase up to 10 million of its shares, or about 4.5% of the ...